Clinical Trial Update: Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome [NA]

View source ↗

Summary

A terminated clinical trial evaluated the effects of fenofibrate on metabolic and reproductive parameters in polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Polycystic Ovary Syndrome | NA | Status: TERMINATED